Who is sponsoring NCT06268548?

NCT06268548 is sponsored by Cairo University.

What drugs are being tested in NCT06268548?

Interventions in NCT06268548: Manual diaphragmatic activation.

What condition does NCT06268548 study?

NCT06268548 studies Diaphragm Dysfunction.

Is NCT06268548 still recruiting?

NCT06268548 is currently status unknown. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT06268548

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Manual Diaphragmatic Activation on Diaphragm Function in Patients With Gastroesophageal Reflux Disease

Status unknown NA Last updated 20 February 2024

What this trial tests

NA trial testing Manual diaphragmatic activation in Diaphragm Dysfunction in 30 participants. Status unknown.

Timeline

15 September 2023

Primary endpoint
20 February 2024

27 February 2024

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	15 September 2023
Primary completion	20 February 2024
Estimated completion	27 February 2024
Sites	1 location across Egypt

Drugs / interventions tested

Manual diaphragmatic activation

Conditions studied

Diaphragm Dysfunction — all drugs for Diaphragm Dysfunction →

Sponsor

Cairo University

Who can join

Adults 20 to 50, any sex, with Diaphragm Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to investigate Effect of manual diaphragmatic activation on diaphragm function in patients with gastroesophageal reflux disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diaphragm Dysfunction

Currently open trials in the same condition.

NCT06420999 — Incidence and Impact of ICU-acquired Diaphragm Weakness · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06268548 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06268548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing